| |NOVEMBER 20244The regenerative medicine market in India is on the rise as technology is developing; there is an increase in demand for innovative treatment, and rise in chronic diseases. This sector is estimated to grow at a CAGR of over 20 percent and in fact, will play a big role in the country's healthcare landscape. This novel approach fills a critical need for treating diseases such as cardiovascular diseases, diabetes, neurodegenerative disorders, and orthopedic injuries, providing promise for treatment of patients with conditions once thought to be untreatable or life limiting. The primary driver of this market is India's rising burden of non-communicable diseases. Given the rapidly aging population and the increasing incidence of lifestyle diseases, there is a strong need for treatments beyond traditional symptom control. This is highly attractive to patients as well as to healthcare providers, since regenerative medicine implies potentially curative solutions. Moreover, the supportive stance of the government through initiatives like the "Make in India" program and tax breaks for biotech firms has inspired domestic companies to spend on research and development. India is increasingly viewed as a hub for clinical trials, with its large and genetically diverse population an ideal base from which to test new therapies. Also, the development of regenerative medicine is in part driven by the presence of academic and clinical research institutions. Indian research institutes and universities are actively working with global entities towards knowledge transfer as well as introduction of most advanced therapies in Indian market. In addition, private and public sectors are investing further to bridge the gap between research and clinical application.Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback and suggestions. Sudhakar SinghEditoreditor@indiapharmaoutlook.comHealing Beyond Boundaries of Medicine Vol 2 · Issue 03 -11 · NOVEMBER , 2024Publisher Alok ChaturvediEditor Sudhakar SinghAssistant Editor Roshan AktharEditorial TeamViswanathan AThiruamuthan T K GM - Media & Graphic Designing VisualizerPrabhu DuttaSenior DesignerRajesh R BDesignerAruna k Suanya BanerjeeAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
< Page 3 | Page 5 >